Abstract
To the Editor: A recent report by Kern et al. ( [1][1]) described molecular mechanisms of apoptosis in human hepatocellular carcinoma cell lines in response to treatment with the selective cyclooxygenase-2 (COX-2) inhibitor (coxib), celecoxib. In their study, the authors treated Huh7 and HepG2
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
